Lead Biotechnology is Agricultural Chemicals in China that focus on pharmaceutical intermediates business. Founded in 2015. They cover business area such as developer, manufacturer, biochemical product, amino acid, food ingredient, feed ingredient, vitamin, raw pharmaceutical chemical, enzyme, pharmaceutical intermediate, company, research, agriculture, biotechnology.
2015
( 9 years old in 2024 )
Pharmaceutical Intermediates
-
4th Floor, Building C11, Bio-Nano Park
No.218 Xinghu Street, Suzhou Industrial Park
Suzhou, Jiangsu
China
Private
developermanufacturerbiochemical productamino acidfood ingredientfeed ingredientvitaminraw pharmaceutical chemicalenzymepharmaceutical intermediatecompanyresearchagriculturebiotechnology
* We use standard office opening hours in near Lead Biotechnology's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Lead Biotechnology is Agricultural Chemicals business from China that founded in 2015 (9 years old in 2024), Lead Biotechnology business is focusing on Pharmaceutical Intermediates.
Lead Biotechnology headquarter office and corporate office address is located in 4th Floor, Building C11, Bio-Nano Park No.218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu China.
Lead Biotechnology was founded in China.
In 2024, Lead Biotechnology is currently focus on pharmaceutical intermediates sector.
Above is snippet of Google Trends for "pharmaceutical intermediates" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Lead Biotechnology, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
